Is Gabapentin legal in Guyana?

Legal status

Not established on this record, and the search that returned nothing is the finding. The dossier records what it calls English language searches for «gabapentina» and «gabapentin», together with spelling variants and the chemical name, against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, and no current named entry and no closed group rule was proved anywhere in the complete instrument. No placement is asserted here in either direction. Gabapentin is tested under its own name rather than as a member of a sedative class. It is a mainstream anticonvulsant and neuropathic pain medicine, and no named entry for it was proved. A search that returns nothing proves that nothing was found in what was read. It does not prove the substance is lawful in Guyana, and this cell does not say that it is. The search was recorded on 20 September 2026.

Consequences if caught

Capital exposure: none. Guyana's Cap. 10:10 carries no death penalty at any tier; section 5(1) sets the indictable trafficking ceiling at life imprisonment, so the worst outcome this Act reaches is a life sentence. That holds whether or not this substance turns out to be scheduled, which is why the heading can be stated while the placement cannot. No ceiling is assigned to this row, because controlled status was not settled from the primary instrument, so on this record no penalty article attaches at all. An unproved placement is not a clearance, and gabapentin has been brought under control in several countries in recent years. If a named entry or a printed group rule is later proved, section 5(1) is the ceiling that would apply.

If prescribed or medical

Deferred, and for two separate reasons. The dossier carries no Guyanese prescription rule, import permit, personal medicine allowance or Ministry authorisation route at all, and it also proves no schedule placement for this substance, so neither the traveller rule nor the placement it would attach to is available. This is a very commonly prescribed medicine, so the absence of both a placement and a traveller rule is a real gap for a patient rather than a technicality. Settle it with the Guyanese authorities before travelling rather than from this cell.

Documentation

A prescriber's letter explaining the neuropathic pain or epilepsy indication is worth having. Carry any medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because an unproved placement is not a clearance and an officer's view of the material is what a traveller meets first. The search recorded for this row was read on 20 September 2026 and returned no named entry.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Guyana’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.